Location: Home
  • search
  • go
  • Relate News
  • 12/9/2021CANbridge Pharma Launches IPO on the Main Board of Hong Kong Stock Ex...
  • 12/9/2021Simcere Pharma and Immunophage Gain Three New Drug IND Approvals in Ch...
  • 12/9/2021China Extends Crackdown of BMI Frauds for Another Year
  • 12/8/2021NMPA Issues the List of Reference Formulations for GQCE Studies (49th ...
  • 12/8/2021CDE Issues the Technical Guidelines for Clinical Trials of Weight Cont...
  • 12/8/2021CDE Issues Three Preclinical Guidance Documents for Covid-19 Drugs
  • 12/8/2021CDE Issues the Technical Guidelines for Application of Biomarkers in C...
  • 12/8/2021CDE Solicits Comments on the Technical Guidelines for Clinical Evaluat...
  • 12/8/2021CDE Solicits Comments on the Technical Guidelines for Endpoints in Adv...
  • 12/8/2021Shanghai Pharma and Syntegon Partner to Promote Continuous Manufacturi...
  • 12/8/2021China Approves Brii Biosciences' COVID-19 Treatment
  • 12/8/2021Three Chinese Biopharma Firms to Start Producing Russian Covid-19 Vacc...
  • 12/7/2021Sanofi Scores A Trademark Win in China
  • 12/6/2021Ji Xing Completes P1 Study of Aficamten, A Potential Next-Gen Cardiac...
  • 12/6/2021Junshi Granted Chinese sNDA Approval for Toripalimab in Combo with Cis...
  • 12/6/2021Rhythm Enters Licensing Deal with RareStone to Commercialize Rare Obes...
  • 12/6/2021SoftBank Reportedly in Investment Talks with Chinese mRNA Vaccine Firm...
  • 12/6/2021Fujifilm Irvine Scientific Establishes Innovation Center in China
  • 12/6/2021Chinese Official A 'Hero' After Forcing Biogen to Cut Cost of Treatmen...
  • 12/6/2021Maximizing China Access for Innovative Therapies (PharmExec)
  • 12/6/2021Snapshot of the 67 Novel Drug Products Included in the 2021 NRDL Thru ...
  • 12/5/2021China Made Solid Reform and Regulatory Advances on Multiple Fronts Las...
  • 12/5/2021Biogen's Spinraza, Fosun-Kite's Yescarta and A Controversial Alzheimer...
  • 12/5/2021Innovent and Lilly Announce Successful Expansion of Sintilimab in Chin...
  • 12/3/2021FDA Rejects BeyondSpring's NDA for Neutropenia Therapy
  • 12/3/2021BeiGene and EUSA Announce CN Approval of SYLVANT (Siltuximab for Inje...
  • 12/3/2021CDE Issues the Technical Guidelines for Long Term Follow-up Clinical R...
  • 12/3/2021CDE Issues Two Technical Guidelines for Non-clinical Research and Asse...
  • 12/3/2021Recent Executive Moves
  • 12/2/2021NMPA Solicits Comments on the Draft Guidelines for Pharmacovigilance I...
  • Page:102/719 Total number of articles:21546: [First][<<] [100] [101] [102] [103] [104] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group